Skanray Chooses Tata Elxsi as Strategic Partner to Transform Advanced Surgical Imaging Technology

05 August 2024 | Monday | News

Partnership Aims to Enhance Diagnosis and Treatment with Cutting-Edge Tech; Focus on Expanding Skanray’s Device Portfolio and Building Advanced Analytics Cloud Platform
Picture Courtsey | Public Domain

Picture Courtsey | Public Domain

Skanray, a leading global MedTech R&D and Manufacturing company specialising in diagnostic imaging, critical care and surgery/OT solutions, has chosen Tata Elxsi as a strategic partner for advanced surgical imaging core technology and software platform development. This collaboration aims to revolutionise diagnosis and treatment by leveraging cutting-edge technology modules, making them predictable, accurate, and consistent.

Skanray is actively pursuing a long-term strategy to expand its portfolio by including new device families and modalities. This initiative aims to build a suite of reusable modules and components for medical devices, alongside the development of an advanced analytics cloud platform.

Tata Elxsi will lead a software platform-led approach to diagnostics that will support all imaging, critical care and surgical systems from the Skanray family, ensuring interoperability, compatibility and multi-modal functionality. This platform will also incorporate the latest technologies and process efficiencies from AI and GenAI.

Combining Skanray's expertise in medical devices, core component technology, systems and applications with Tata Elxsi's domain experience in medical imaging, software platform development, digital capabilities in cloud, AI and analytics, and ready-to-use solution accelerators provides Skanray an opportunity to redefine the landscape of medical technology, with advanced, modular, and yet affordable diagnostics systems.

Pankaj Madhukar Wani, Head of Healthcare Business Unit at Tata Elxsi, said, "The diagnostic imaging landscape is being transformed by software and digital technologies such as cloud and AI. We are delighted to be supporting Skanray in realising their long-term strategy and vision for healthcare. This long-term partnership will help create transformative solutions for healthcare facilities and patients worldwide."

"By combining Skanray's core technology and deep understanding of medical applications with Tata Elxsi's capabilities in futuristic technology, we are poised to drive significant advancements in healthcare delivery. Our collaborative efforts will result in solutions that are not only technologically advanced, but are also operator-friendly and cost-effective, helping healthcare providers deliver significantly improved health outcomes for patients," said Priyanka Chatterjee, VP – Corporate Communications at Skanray Technologies Ltd.

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close